Scholar@UC Upgraded to Enhance Both the Use and Access of the University s Digital Repository
Scholar@UC, the University of Cincinnatis digital repository, has been updated and includes enhanced submission and viewing features, including:
- improved look & feel
- content dashboard for easier management of submitted works
- batch work creation and upload upload an entire folder of works simultaneously or create multiple works at once including from folders
- usage analytics of content (views and downloads)
- new work-relation model allowing works to be nested and related in meaningful ways
- social media sharing widgets.
All content previously in Scholar@UC was migrated from the old platform, with files validated and the metadata and relationships maintained.
Scholar@UC is a digital repository that enables the University of Cincinnati community to share its research and scholarly work with a worldwide audience. Faculty and staff can use Scholar@UC to collect their work in one location and create a durable and citeable record of papers, presentations, publications, datasets or other scholarly creations. Students, through an approval process, may contribute capstone projects such as senior design projects, theses and dissertations.
The mission of Scholar@UC is to preserve the permanent intellectual output of UC, to advance discovery and innovation, to foster scholarship and learning through the transformation of data into knowledge, to collect a corpus of works that can be used for teaching and to enhance discoverability and access to these resources.
Scholar@UC is an open source, agile development project supported in partnership by the University of Cincinnati Libraries and IT@UC. To submit or view works in Scholar@UC, visit
. Contact the Scholar@UC Team (
) with any questions.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.